Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPRENORPHINE for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where BUPRENORPHINE was used for Multiple sclerosis.

Most Reported Side Effects for BUPRENORPHINE

Side Effect Reports % Deaths Hosp.
Drug dependence 16,730 20.4% 1,996 1,362
Overdose 13,977 17.0% 6,924 1,047
Death 13,604 16.6% 13,594 378
Toxicity to various agents 10,906 13.3% 8,962 1,846
Pain 8,219 10.0% 658 840
Drug withdrawal syndrome 7,149 8.7% 275 568
Emotional distress 6,159 7.5% 124 187
Drug abuse 4,344 5.3% 1,834 1,431
Drug ineffective 4,261 5.2% 549 698
Dependence 3,184 3.9% 341 61
Product adhesion issue 3,158 3.9% 1 26
Drug withdrawal syndrome neonatal 2,979 3.6% 43 534
Nausea 2,927 3.6% 551 636
Foetal exposure during pregnancy 2,538 3.1% 71 627
Maternal exposure during pregnancy 2,109 2.6% 597 715

Other Indications for BUPRENORPHINE

Product used for unknown indication (37,303) Pain (28,541) Drug dependence (4,540) Drug use disorder (1,772) Back pain (1,182) Analgesic therapy (510) Pain management (457) Arthralgia (270) Drug abuse (196) Fibromyalgia (190)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

BUPRENORPHINE Full Profile All Multiple sclerosis Drugs BUPRENORPHINE Demographics BUPRENORPHINE Timeline